Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients: A Randomized Controlled Trial

NCT03182699 is registered in ClinicalTrials.gov with Rainer Oberbauer as lead sponsor.

NCT NCT03182699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03182699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients: A Randomized Controlled Trial
Lead sponsor
Rainer Oberbauer
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2017
Completion date
December 20, 2019
Enrollment
62 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease requiring chronic dialysis, left ventricular hypertrophy, secondary hyperparathyroidism